Versant Capital Management’s Corcept Therapeutics CORT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $15K | Buy |
172
+145
| +537% | +$8.76K | ﹤0.01% | 2076 |
|
|
2026
Q1 | $1.09K | Sell |
27
-7
| -21% | -$262 | ﹤0.01% | 2643 |
|
|
2025
Q4 | $1.18K | Buy |
34
+7
| +26% | +$550 | ﹤0.01% | 2514 |
|
|
2025
Q3 | $2.24K | Hold |
27
| – | – | ﹤0.01% | 2390 |
|
|
2025
Q2 | $1.98K | Hold |
27
| – | – | ﹤0.01% | 2383 |
|
|
2025
Q1 | $3.08K | Hold |
27
| – | – | ﹤0.01% | 2190 |
|
|
2024
Q4 | $1.36K | Hold |
27
| – | – | ﹤0.01% | 2130 |
|
|
2024
Q3 | $1.25K | Hold |
27
| – | – | ﹤0.01% | 1694 |
|
|
2024
Q2 | $877 | Hold |
27
| – | – | ﹤0.01% | 1703 |
|
|
2024
Q1 | $680 | Sell |
27
-22
| -45% | -$520 | ﹤0.01% | 1632 |
|
|
2023
Q4 | $1.59K | Sell |
49
-57
| -54% | -$1.56K | ﹤0.01% | 1366 |
|
|
2023
Q3 | $2.89K | Hold |
106
| – | – | ﹤0.01% | 1177 |
|
|
2023
Q2 | $2.36K | Buy |
106
+22
| +26% | +$506 | ﹤0.01% | 1312 |
|
|
2023
Q1 | $1.82K | Hold |
84
| – | – | ﹤0.01% | 1296 |
|
|
2022
Q4 | $1.71K | Sell |
84
-13
| -13% | -$326 | ﹤0.01% | 1178 |
|
|
2022
Q3 | $2K | Buy |
97
+9
| +10% | +$241 | ﹤0.01% | 1058 |
|
|
2022
Q2 | $2K | Hold |
88
| – | – | ﹤0.01% | 1076 |
|
|
2022
Q1 | $2K | Buy |
88
+70
| +389% | +$1.49K | ﹤0.01% | 1113 |
|
|
2021
Q4 | $0 | Hold |
18
| – | – | ﹤0.01% | 1458 |
|
|
2021
Q3 | $0 | Hold |
18
| – | – | ﹤0.01% | 1468 |
|
|
2021
Q2 | $0 | Hold |
18
| – | – | ﹤0.01% | 1467 |
|
|
2021
Q1 | $0 | Hold |
18
| – | – | ﹤0.01% | 1532 |
|
|
2020
Q4 | $0 | Hold |
18
| – | – | ﹤0.01% | 1363 |
|
|
2020
Q3 | $0 | Hold |
18
| – | – | ﹤0.01% | 1327 |
|
|
2020
Q2 | $0 | Hold |
18
| – | – | ﹤0.01% | 1331 |
|
|
2020
Q1 | $0 | Buy |
+18
| New | +$223 | ﹤0.01% | 1362 |
|
Other funds holding CORT
HWAM
EF
FCBT
PA
ERIC
GI
WPC
BCG
CWP